116 related articles for article (PubMed ID: 811729)
21. [Development of measles vaccination in Austria].
Huber EG; Rannon L
Padiatr Padol; 1973; 8(3):247-56. PubMed ID: 4715034
[No Abstract] [Full Text] [Related]
22. [Measles vaccination].
Enders G
Zentralbl Bakteriol Orig A; 1972 May; 220(1):273-83. PubMed ID: 4145578
[No Abstract] [Full Text] [Related]
23. Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. I. Different results with undiluted human diploid cell and chick embryo fibroblast vaccines.
Sabin AB; Flores Arechiga A; Fernández de Castro J; Sever JL; Madden DL; Shekarchi I; Albrecht P
JAMA; 1983 May; 249(19):2651-62. PubMed ID: 6341638
[TBL] [Abstract][Full Text] [Related]
24. Development of extremely attenuated live measles virus vaccine (CAM-EX).
Ueda S; Takahashi M; Kurimura T; Minekawa Y; Suzuki N
Biken J; 1972 Sep; 15(3):173-7. PubMed ID: 4643692
[No Abstract] [Full Text] [Related]
25. FURTHER STUDY OF THE USE OF LIVE ATTENUATED MEASLES-VIRUS VACCINE.
CHU FT; CHANG IH; SUNG HY; LING CC
Paediatr Indones; 1964; 149():42-8. PubMed ID: 14279960
[No Abstract] [Full Text] [Related]
26. Vaccine-induced hypersensitivity: reactions to live measles and mumps vaccine in prior recipients of inactivated measles vaccine.
Harris RW; Isacson P; Karzon DT
J Pediatr; 1969 Apr; 74(4):552-63. PubMed ID: 5812962
[No Abstract] [Full Text] [Related]
27. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana.
Nkrumah FK; Osei-Kwasi M; Dunyo SK; Koram KA; Afari EA
Bull World Health Organ; 1998; 76(4):353-9. PubMed ID: 9803586
[TBL] [Abstract][Full Text] [Related]
28. Combined measles-rubella vaccines. Virus dose and serologic response.
Landrigan PJ; Murphy KB; Meyer HM; Parkman PD; Eddins DL; Witte JJ
Am J Dis Child; 1973 Jan; 125(1):65-7. PubMed ID: 4683961
[No Abstract] [Full Text] [Related]
29. A new combined trivalent live measles (AIK-C strain), mumps (Hoshino strain), and rubella (Takahashi strain) vaccine. Findings in clinical and laboratory studies.
Makino S; Sasaki K; Nakayama T; Oka S; Urano T; Kimura M; Kawana R; Yamamura AM
Am J Dis Child; 1990 Aug; 144(8):905-10. PubMed ID: 2198807
[TBL] [Abstract][Full Text] [Related]
30. Five cases of measles secondary vaccine failure with confirmed seroconversion after live measles vaccination.
Hirose M; Hidaka Y; Miyazaki C; Ueda K; Yoshikawa H
Scand J Infect Dis; 1997; 29(2):187-90. PubMed ID: 9181657
[TBL] [Abstract][Full Text] [Related]
31. [Studies on immunity to measles. II. Prophylactic and serological studies on the use of live and attenuated measles-virus vaccine].
Egami T
Kumamoto Igakkai Zasshi; 1966 May; 40(5):539-62. PubMed ID: 4164172
[No Abstract] [Full Text] [Related]
32. INACTIVATED MEASLES VIRUS VACCINE SUBSEQUENTLY CHALLENGED WITH LIVE ATTENUATED MEASLES VIRUS VACCINE.
KIMURA M; ISHIGURO Y
Jpn J Med Sci Biol; 1965 Feb; 18():65-71. PubMed ID: 14300296
[No Abstract] [Full Text] [Related]
33. IMMUNIZATION AGAINST MEASLES: DEVELOPMENT AND EVALUATION OF A HIGHLY ATTENUATED LIVE MEASLES VACCINE.
SCHWARZ AJ
Ann Paediatr; 1964; 202():241-52. PubMed ID: 14140673
[No Abstract] [Full Text] [Related]
34. [Studies on the combined use of attenuated and live vaccines for measles. 1. Evaluation of vaccination with live vaccine after administration of the attenuated vaccine once or twice].
Seki T
Nihon Shonika Gakkai Zasshi; 1966 Dec; 70(12):1340-9. PubMed ID: 6010153
[No Abstract] [Full Text] [Related]
35. Measles vaccine reactions in a virgin population.
Black FL; Woodall JP; Pinheiro FD
Am J Epidemiol; 1969 Feb; 89(2):168-75. PubMed ID: 5765956
[No Abstract] [Full Text] [Related]
36. Experimental study of a further attenuated live measles vaccine of the Sugiyama strain in Iran.
Mirchamsy H; Shafyi A; Rafyi MR; Bahrami S; Nazari P; Fatemie S
J Hyg (Lond); 1974 Apr; 72(2):273-9. PubMed ID: 4522721
[TBL] [Abstract][Full Text] [Related]
37. [Clinical and immunological reactions after measles vaccination with cleavage vaccine and live vaccine].
Stehr K; Enders G; Suschke HJ; Spiess H
Monatsschr Kinderheilkd (1902); 1970 Jun; 118(6):383-7. PubMed ID: 5523685
[No Abstract] [Full Text] [Related]
38. Antibody response and clinical reactions in children given measles vaccine with immunoglobulin.
Elliman D
Br Med J (Clin Res Ed); 1986 Jun; 292(6535):1597-8. PubMed ID: 3087532
[No Abstract] [Full Text] [Related]
39. [Studies on the combined use of attenuated and live vaccines for measles. 2. Evaluation of vaccination with live vaccine after a long period following administration of the attenuated vaccine 2 or 3 times].
Seki T
Nihon Shonika Gakkai Zasshi; 1966 Dec; 70(12):1350-62. PubMed ID: 6010154
[No Abstract] [Full Text] [Related]
40. Immunogenicity and safety of standard-titer AIK-C measles vaccine in nine-month-old infants.
Tsai HY; Huang LM; Shih YT; Chen JM; Jiang TM; Tsai CH; Lee CY
Viral Immunol; 1999; 12(4):343-8. PubMed ID: 10630793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
